OccupationalTherapy.com Phone: 866-782-9924


Occupational Therapy and Scleroderma (Systemic Sclerosis)

Occupational Therapy and Scleroderma (Systemic Sclerosis)
Janet Poole, PhD, OTR/L, FAOTA
June 3, 2014

This text based course is a transcript of the live webinar titled, "Occupational Therapy and Scleroderma (Systemic Sclerosis)", presented by Janet Poole, Ph.D., OTR/L, FAOTA.

>> Dr. Janet Poole:  It is a pleasure to speak to you today about Scleroderma and the Role of OT.  The objectives of this presentation are to identify symptoms of systemic sclerosis or scleroderma; to discuss occupational therapy intervention to increase joint motion, reduce pain and manage daily tasks, fatigue and Raynaud’s phenomenon; and to review the evidence for occupational therapy interventions.  I am going to try to integrate the evidence into the talk as we go through the different topics.

Definition of Scleroderma

Scleroderma or systemic sclerosis is a rare multi-system autoimmune disease characterized by thickening of the skin, vascular insufficiency or involvement and fibrosis of the internal organs, including the lungs, the heart, the kidneys and the gastrointestinal tract.  The cause is unknown, but the autoimmune processes result in abnormal collagen build-up.  The prevalence is about 240 persons per 1 million, and both the prevalence and the incidence are four times greater in women than in men.  The onset is usually between 30 to 40 years of age, when people are at their most productive.  The average 10-year survival rate is now about 70% to 80%.  The following are two websites that might be helpful sources of information for you: http://scleroderma.org/ and http://www.niams.nih.gov/Health_Info/Scleroderma/default.asp.

Systemic sclerosis is divided into two particular subtypes, limited cutaneous systemic sclerosis and diffuse cutaneous systemic sclerosis. 

Limited Cutaneous Systemic Sclerosis

In the limited cutaneous systemic sclerosis, there is gradual thickening that is limited to the distal extremities and the face.  Later there is involvement of the internal organs.  The limited subtype was formally referred to as the CREST syndrome, which is an acronym that describes the symptoms typically seen in scleroderma. 

"C".The C is for calcinosis, that are subcutaneous calcium deposits that may accumulate most often on the fingers, but also on the forearms and to a lesser extent on the ischial tuberosities or the lateral malleoli.  Pain and infection can result as the deposits become inflamed, ulcerate, and protrude the skin.  They can also extrude whitish, calcific material. 

"R".The R is for Raynaud’s.  In Raynaud’s phenomenon, there is a restriction, constriction or narrowing of the blood vessels in response to cold and stress.  Severe untreated Raynaud’s may lead to sores or ulcers.  Those can become infected and heal very slowly or not at all because of the vascular involvement, and it can to amputations or auto-amputations. 

"E". The E is for esophageal dysfunction.  That includes heartburn, dysphagia, or reflux. 

"S".The S is for sclerodactyly or the thickening of the skin on the fingers and usually that is the tell-tale sign of scleroderma. 

"T".The T is for telangiectasias.  These are dilated blood vessels near the surface of the skin.  They appear as small, red or purple spider-like spots usually on the fingers, palms, lips, face, and tongue.  There is nothing severe about them, except that cosmetically they are oftentimes upsetting to people that have scleroderma. 

Continued and its subsidiaries provide professional education authored by qualified Subject Matter Experts for continuing education purposes. These materials are intended for educational purposes and do not constitute medical advice or a substitute for individual clinical judgment. Continued is not a clinical healthcare provider; the licensed professional is solely responsible for ensuring that the application of any techniques or information presented is within their legal scope of practice and jurisdictional requirements.


janet poole

Janet Poole, PhD, OTR/L, FAOTA

Janet L. Poole, PhD, OTR/L, is a Professor and Director of the Occupational Therapy Graduate Program at the University of New Mexico.  Dr. Poole has worked with many people with different rheumatic diseases, published and presented on rheumatology-related content to students and health professionals, and mentored students’ research projects focused on occupational performance challenges faced by people with arthritis. Dr. Poole served as President of the Association of Rheumatology Professionals (ARP) from 2019-2020, and in 2022 the ARP honored Dr. Poole with the Master’s Designation, for those  “who have made outstanding contributions to the field of rheumatology through service to the ACR/ARP and advancements in research, practice, education, and/or advocacy from the ARP”.



Related Courses

Scleroderma And The OT Role
Presented by Janet Poole, PhD, OTR/L, FAOTA
Video
Course: #5904Level: Introductory1 Hour
Systemic sclerosis (scleroderma) is an autoimmune connective tissue disease affecting the skin, internal organs, and blood vessels. People with scleroderma often develop severe contractures in their hands that make it very difficult to perform daily occupations. This course will review symptoms of scleroderma and the occupational therapist's role. Specific interventions to increase joint motion and manage daily tasks will be presented.

Occupational Therapy: Key To Participation In Daily Life For People With Rheumatic Disease
Presented by Janet Poole, PhD, OTR/L, FAOTA
Video
Course: #5850Level: Intermediate1 Hour
Occupational performance deficits and work disability in people with rheumatic diseases remain high despite advances in medical and pharmacological management Yet, people are often not referred to occupational therapy unless there are hand impairments. This presentation reviews the role and need for occupational therapy in rheumatology care, including interventions to improve hand function, self-management of fatigue, pain, stress and anxiety, and strategies to prevent work disability.

Joint Hypermobility Syndromes: Assessment and Intervention
Presented by Valeri Calhoun, MS, OTR/L, CHT
Video
Course: #5376Level: Intermediate1 Hour
This course will cover upper extremity assessment and treatment strategies for the pediatric/young adult population affected by joint hypermobility syndromes. The treatment focuses on both orthopedic strategies along with adaptive methods for these individuals.

Shoulder Arthroplasty: A Clinician's Approach To Diagnosis, Complications, And Rehabilitation, Part 1
Presented by Rina Pandya, PT. DPT, FHEA, PGLTHE
Video
Course: #6401Level: Advanced2 Hours
This course discusses the anatomical structures and arthrokinematics of the shoulder joint, which are essential for successful rehabilitation following shoulder arthroplasty. Participants will gain insights into recognizing indications for Total Shoulder Arthroplasty (TSA), distinguishing between diverse pathologies, and understanding conditions warranting TSA intervention. Additionally, attendees will hone their skills in conducting thorough pre-operative assessments for patients slated for shoulder arthroplasty, enhancing their proficiency in guiding optimal patient care pathways. This is Part 1 of a 2-part series.

Shoulder Arthroplasty: A Clinician's Approach To Diagnosis, Complications, And Rehabilitation, Part 2
Presented by Rina Pandya, PT. DPT, FHEA, PGLTHE
Video
Course: #6404Level: Advanced2 Hours
This course discusses the anatomical structures and arthrokinematics of the shoulder joint, which are essential for successful rehabilitation following shoulder arthroplasty. Participants will gain insights into recognizing indications for Total Shoulder Arthroplasty (TSA), distinguishing between diverse pathologies, and understanding conditions warranting TSA intervention. Additionally, attendees will hone their skills in conducting thorough pre-operative assessments for patients slated for shoulder arthroplasty, enhancing their proficiency in guiding optimal patient care pathways. This is Part 2 of a 2-part series.